Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease
Craig Ritchie(Western General Hospital), Alistair Burns(University of Manchester), Matt Norton(Alzheimer’s Research UK), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Jim Pearson(Alzheimer Scotland), Richard Perry(Imperial College Healthcare NHS Trust), Martin N. Rossor(National Hospital for Neurology and Neurosurgery), Sube Banerjee(University of Nottingham), Tom C. Russ(National Health Service Scotland), Adam Waldman(Royal Society of Edinburgh), Bob Barber(Royal College of Psychiatrists), Clive Holmes(University of Eastern Finland), James Pickett(Alzheimer's Society), Andrew Boaden(Alzheimer's Society), Iracema Leroi(Trinity College Dublin), Wai Lup Wong(East and North Hertfordshire NHS Trust), Simon Lovestone(Royal Buckinghamshire Hospital), Jeremy D. Isaacs(St George’s University Hospitals NHS Foundation Trust), John T. O’Brien(North Tyneside General Hospital)
Cited by 3
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k